Book a Demo
Sun Yat-Sen
Gray shield icon
Is this you?
Claim your profile.

Sun Yat-Sen

AS SEEN ON
Nature Portfolio, Asia-Pacific Journal of Oncology Nursing (APJON), NEOMERS, American Journal of Ophthalmology, Annals of Allergy, Asthma and Immunology

Geo Focus

Coverage Attributes:

Beta
Informative: 47 %
Data Driven: 37 %
Promotional: 9 %
Opinion: 2 %
Events: 1 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Oncology
  • Immunotherapy
  • Neuroscience
  • Surgery
  • Pathology
  • Environmental Engineering
  • Climate Policy
  • Biotechnology

Pitching Insights

Sun Yat-Sen primarily covers scientific and healthcare-related topics, with a focus on biomedical research, medical treatments, disease studies, clinical trials, and genetics. The articles appear to heavily rely on citing data as well as press releases.

Given this emphasis on data-driven content and press releases, Sun Yat-Sen may be particularly interested in receiving pitches that provide access to new or exclusive research findings within the biomedical field. Press releases for significant clinical trial results or groundbreaking genetic studies could also pique their interest.

It's important for sources reaching out to Sun Yat-Sen to ensure that they can provide credible data and evidence-based insights related to biomedical research and healthcare advancements.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Matthew J.

Matthew J.

News Editor
**************ere@********om
Publications
Nature Portfolio, MDPI, Proceedings of the National Academy of Sciences
Most recent topics
Not enough data
Jiao Tong

Jiao Tong

Publications
Nature Portfolio, Cell Press, biologicalpsychiatryjournal.com, Asia-Pacific Journal of Oncology Nursing (APJON), NEOMERS
Most recent topics
Not enough data
Mohammad Reza

Mohammad Reza

Publications
Nature Portfolio, MDPI
Most recent topics
Not enough data

Articles

Fire Technology journal by Springer Nature

Age-stratified associations of glycemia, blood pressure, and cholesterol with mortality in diabetes: A prospective cohort study - BMC Medicine

Age-stratified associations of glycemia, blood pressure, and cholesterol with mortality in diabetes: A prospective cohort study - BMC Medicine

By: Qiao, Jie, Prevention, Zhiyun, Yu, Deng, Hong, Zhu, Wang, Youmin, Gao, Yan, Tang, Zeng, Zhang, Su, Yang, Mu, Wan, Lin, Hefei, Shi, Lu, Luo, Min, Lulu, Qiang, Chen, Gu, Hu, Yuhong, Bi, Li, Liu, Wu

Background Optimization of HbA1c, blood pressure and cholesterol, referred to as the “ABCs”, is central to the management of diabetes. However, the age-specific associations of these factors with mortality in patients with diabetes remains unclear. Methods In this prospective cohort study, 43,732 Chinese adults aged ≥ 40 years with diabetes were included from the China Cardiometabolic Disease and Cancer Cohort (4C) Study. Participants were stratified by age (< 55, 55-<65, 65-<75, ≥ 75 years). Cox proportional hazards regression and Fine-Gray competing risk models were employed to estimate the associations of HbA1c, systolic blood pressure (SBP), and low-density lipoprotein cholesterol (LDL-C) with all-cause, cardiovascular, and non-cardiovascular mortality across age groups. Relative importance and population attributable fractions (PAFs) were computed for each metabolic factor. Results During a median follow-up of 10.1 years, 3,975 deaths were documented. Age significantly modified the associations of HbA1c, SBP, and LDL-C with all mortality outcomes (all P for interaction < 0.05). Among participants aged < 75 years, HbA1c showed graded positive associations with all-cause, cardiovascular, and non-cardiovascular mortality. The SBP thresholds associated with increased mortality risk were 140 mmHg in those aged < 65 years and 160 mmHg in those aged 65–<75 years. Among those aged ≥ 75 years, however, the patterns of these associations differed markedly. Elevated mortality risk was observed only at HbA1c ≥ 9%, with a hazard ratio (HR) of 1.51 (95% confidence interval [CI]: 1.19–1.91) for all-cause mortality and a subdistribution hazard ratio (SHR) of 1.70 (95% CI: 1.23–2.36) for cardiovascular mortality, while SBP showed no significant association with any mortality outcome in this age group. Moreover, LDL-C emerged as a significant risk factor for cardiovascular mortality. Compared with participants with LDL-C < 1.8 mmol/L, those with LDL-C of 1.8–<2.6 mmol/L exhibited a significantly higher risk (SHR: 1.86; 95% CI: 1.11–3.11). Additionally, LDL-C had the largest PAF for cardiovascular mortality (9.6%) within this age group. Conclusions The impacts of ABC factors on mortality risk vary substantially by age among adults with diabetes. In patients aged ≥ 75 years, less stringent glycemic and blood pressure targets may be appropriate, whereas lipid management remains critically important for reducing cardiovascular mortality.

© 2026 Intelligent Relations